Generic Peptides
Generic Peptides Somatropin 100 to 200 IU HGH Kits for Sale
No reviews yet
$280.00
Out of stock
Generic Peptides
Generic Peptides AOD 9604 2 mg and 5 mg Research Grade Vials
Injection · 2 mg · vial
Out of stock
$54.00
Generic Peptides AOD 9604 is the hGH fragment 176-191 supplied as a lyophilized research powder in two vial sizes: 2 mg and 5 mg.
GMP-manufactured, each batch is HPLC-verified with the Certificate of Analysis on file. AOD 9604 for sale with U.S. domestic and international shipping and dispatch within two business days after payment.
Discreet plain packaging
Worldwide reship guarantee
Crypto & card accepted
Product overview
Generic Peptides AOD 9604 - 2 mg and 5 mg Vials
Generic Peptides AOD 9604 is the human growth hormone fragment that runs from residue 176 to 191, sold as a lyophilized research powder in 2 mg and 5 mg vials. It is a 16 amino acid peptide with a tyrosine in place of phenylalanine at the N-terminus. Keeping only one region of the molecule, it is read against the full hormone, Somatropin.
- Two vial sizes - 2 mg and 5 mg
- 16 amino acid hGH fragment 176-191
- Lyophilized powder - needs a solvent
- GMP-made, HPLC-verified, COA on file
Variant Comparison
Both vials hold the same peptide, so the choice is how much material one series needs.
| Variant | Dosage | Form and quantity | Best use |
|---|---|---|---|
| AOD 9604 2 mg | 2 mg | Lyophilized vial | Short runs |
| AOD 9604 5 mg | 5 mg | Lyophilized vial | Extended series |
The 5 mg vial carries two and a half times the material of the 2 mg vial and is the size with a U.S. domestic option. The AMPK activator AICAR and the receptor agent Semaglutide sit in separate metabolic arms.
How AOD 9604 Works
The fragment is described as acting on fat metabolism through increased expression of beta-3 adrenergic receptors in adipose tissue, a mechanism worked out in mouse models, and it keeps that lipolytic action without raising IGF-1. The human record is mixed: a 12 week trial at 1 mg per day reported an average loss of 2.6 kg against 0.8 kg on placebo, while a later 24 week phase 2b study in 536 subjects did not show a significant effect, and development was terminated in 2007.
Reconstitution & Storage
The powder is dissolved with sterile or bacteriostatic water, which is not in the pack, added down the vial wall and swirled rather than shaken. Divide the amount on the label by the millilitres added, so 5 mg in 2 mL gives 2.5 mg per mL. Keep the lyophilized vial at 2-8 C, protected from light, and the mixed solution at 2-8 C for about four weeks.
Dosage & Administration
No human dose is stated here and the vial is not a medicine. AOD 9604 has no approved indication and its programme was closed, so nothing on this page is a dosing guide. A GHRH analog such as Tesamorelin works through the growth hormone axis and is not interchangeable with a fragment. Growth hormone fragments sit in WADA class S2.2.3 and are banned in sport at all times.
Supplied for laboratory research only, not for human or veterinary use. Information provided is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before use. AOD 9604 is supplied as a lyophilized powder and stays stable when the vial is kept cold and dry.
Specifications
| Trade Name | AOD 9604 |
| Generic Name | hGH fragment 176-191 |
| Manufacturer | Generic Peptides |
| Dosage | 2 mg or 5 mg per vial |
| Package | Lyophilized powder, one vial |
| Drug Class | Peptide; growth hormone fragment |
| Administration | Subcutaneous (research protocols) |
| Storage | Lyophilized 2-8 C; mixed 2-8 C, 4 weeks |
| Prescription Status | Research use only |
| Verification | Batch details confirmed with supplier |
| Shipping | International about USD 35; USA option on 5 mg |
Stacks
For laboratory research only. Consult a healthcare professional before handling any peptide. Amounts shown are research references, not recommended human doses.
FAQ
Before you ask
Questions, answered
AOD 9604 is a 16 amino acid fragment of human growth hormone, covering residues 176 to 191 with a tyrosine at the N-terminus in place of phenylalanine. Its mass is about 1815 g/mol, its CAS number is 221231-10-3 and its PubChem identifier is 71300630. It was developed as an anti-obesity drug candidate, which is where the generic name comes from.
It is the same molecule reduced to one region. The fragment keeps the reported lipolytic action, said to run through beta-3 adrenergic receptor expression in fat tissue, but it does not raise IGF-1, while whole growth hormone does. That difference was the point of the original programme, and it is why the two are studied in separate arms rather than treated as one substance.
The results were mixed. A 12 week randomised trial using 1 mg per day reported an average loss of 2.6 kg against 0.8 kg on placebo, a difference of about 1.8 kg. A larger 24 week phase 2b study in 536 subjects did not show a significant effect on weight, and the development programme was terminated in 2007. No product was approved from that work.
Sterile or bacteriostatic water is added down the wall of the vial and the contents are swirled, not shaken; the solvent is not included in the pack. A 5 mg vial plus 2 mL gives 2.5 mg per mL, and a 5 mg vial plus 1 mL gives 5 mg per mL. The lyophilized vial is kept at 2-8 C, protected from light, and the mixed solution at 2-8 C for about four weeks.
In the trial record the compound was described as tolerated, with no pronounced systemic effects reported. Injection site reactions are the common local effect for injected peptides, and headache and nausea appear in vendor case write-ups rather than in controlled data. Human data on long term safety are limited, and the half-life of the compound has not been established in the published sources.
Yes. Growth hormone fragments are named in class S2.2.3 of the WADA Prohibited List, and AOD 9604 appears there by name. Substances in that class are prohibited at all times, in and out of competition. The compound is also detectable in urine by LC-MS/MS with a limit of detection of 50 pg/mL, so a laboratory can identify it even though a full detection window is not published.
Yes, both vial sizes are in stock on this page and can be ordered directly. The 2 mg and 5 mg vials ship internationally, and the 5 mg vial also has a U.S. domestic option. International shipping is about USD 35, orders are processed in one to two business days and transit runs four to ten days depending on the destination country.
No reviews yet
Be the first to share your experience with Generic Peptides AOD 9604 2 mg and 5 mg Research Grade Vials
Log in to write a reviewComplete the cycle
Stack it with
Generic Peptides
Generic Peptides BPC-157 5 to 30 mg Lyophilized Vials for Sale
No reviews yet
$43.00
Out of stock
Generic Peptides
Generic Peptides CJC-1295 DAC 2 to 10 mg Vials for Sale
No reviews yet
$35.00
Out of stock